174 related articles for article (PubMed ID: 37433992)
1. The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.
Chen W; Hu L; Lu X; Wang X; Zhao C; Guo C; Li X; Ding Y; Zhao H; Tong D; Wang L; Huang C
Breast Cancer Res Treat; 2023 Oct; 201(3):353-366. PubMed ID: 37433992
[TBL] [Abstract][Full Text] [Related]
2. Mex3a interacts with LAMA2 to promote lung adenocarcinoma metastasis via PI3K/AKT pathway.
Liang J; Li H; Han J; Jiang J; Wang J; Li Y; Feng Z; Zhao R; Sun Z; Lv B; Tian H
Cell Death Dis; 2020 Aug; 11(8):614. PubMed ID: 32792503
[TBL] [Abstract][Full Text] [Related]
3. MEX3A promotes triple negative breast cancer proliferation and migration via the PI3K/AKT signaling pathway.
Jiang S; Meng L; Chen X; Liu H; Zhang J; Chen F; Zheng J; Liu H; Wang F; Hu J; Li Z
Exp Cell Res; 2020 Oct; 395(2):112191. PubMed ID: 32738346
[TBL] [Abstract][Full Text] [Related]
4. Mex-3 RNA binding MEX3A promotes the proliferation and migration of breast cancer cells via regulating RhoA/ROCK1/LIMK1 signaling pathway.
Yan L; Li H; An W; Wei W; Zhang X; Wang L
Bioengineered; 2021 Dec; 12(1):5850-5858. PubMed ID: 34486491
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-139-5p Suppresses Cell Malignant Behaviors in Breast Cancer through Targeting MEX3A.
Chu J; Li T; Li L; Fan H
Comput Math Methods Med; 2021; 2021():6591541. PubMed ID: 34765013
[TBL] [Abstract][Full Text] [Related]
6. MEX3A promotes development and progression of breast cancer through regulation of PIK3CA.
Shi X; Sun Y; Zhang Y; Wang W; Xu J; Guan Y; Ding Y; Yao Y
Exp Cell Res; 2021 Jul; 404(1):112580. PubMed ID: 33811903
[TBL] [Abstract][Full Text] [Related]
7. RNA-Binding Protein MEX3A Interacting with DVL3 Stabilizes Wnt/β-Catenin Signaling in Endometrial Carcinoma.
Yang P; Zhang P; Zhang S
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614043
[TBL] [Abstract][Full Text] [Related]
8. Mex3a promotes oncogenesis through the RAP1/MAPK signaling pathway in colorectal cancer and is inhibited by hsa-miR-6887-3p.
Li H; Liang J; Wang J; Han J; Li S; Huang K; Liu C
Cancer Commun (Lond); 2021 Jun; 41(6):472-491. PubMed ID: 33638620
[TBL] [Abstract][Full Text] [Related]
9. MEX3A determines in vivo hepatocellular carcinoma progression and induces resistance to sorafenib in a Hippo-dependent way.
Fang S; Zheng L; Chen X; Guo X; Ding Y; Ma J; Ding J; Chen W; Yang Y; Chen M; Zhao Z; Tu J; Ji J
Hepatol Int; 2023 Dec; 17(6):1500-1518. PubMed ID: 37460832
[TBL] [Abstract][Full Text] [Related]
10. ROR2 knockdown suppresses breast cancer growth through PI3K/ATK signaling.
Guo M; Ma G; Zhang X; Tang W; Shi J; Wang Q; Cheng Y; Zhang B; Xu J
Aging (Albany NY); 2020 Jul; 12(13):13115-13127. PubMed ID: 32614787
[TBL] [Abstract][Full Text] [Related]
11. Hsa_circ_001569 is an unfavorable prognostic factor and promotes cell proliferation and metastasis by modulating PI3K-AKT pathway in breast cancer.
Xu JH; Wang Y; Xu D
Cancer Biomark; 2019; 25(2):193-201. PubMed ID: 31104012
[TBL] [Abstract][Full Text] [Related]
12. Circular RNA CirCHIPK3 promotes cell proliferation and invasion of breast cancer by sponging miR-193a/HMGB1/PI3K/AKT axis.
Chen ZG; Zhao HJ; Lin L; Liu JB; Bai JZ; Wang GS
Thorac Cancer; 2020 Sep; 11(9):2660-2671. PubMed ID: 32767499
[TBL] [Abstract][Full Text] [Related]
13. LHX6 inhibits the proliferation, invasion and migration of breast cancer cells by modulating the PI3K/Akt/mTOR signaling pathway.
Bi QJ; Men XJ; Han R; Li GL
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3067-3073. PubMed ID: 29863252
[TBL] [Abstract][Full Text] [Related]
14. PLCA8 suppresses breast cancer apoptosis by activating the PI3k/AKT/NF-κB pathway.
Mao M; Chen Y; Jia Y; Yang J; Wei Q; Li Z; Chen L; Chen C; Wang L
J Cell Mol Med; 2019 Oct; 23(10):6930-6941. PubMed ID: 31448883
[TBL] [Abstract][Full Text] [Related]
15. PTENP1/miR-20a/PTEN axis contributes to breast cancer progression by regulating PTEN via PI3K/AKT pathway.
Gao X; Qin T; Mao J; Zhang J; Fan S; Lu Y; Sun Z; Zhang Q; Song B; Li L
J Exp Clin Cancer Res; 2019 Jun; 38(1):256. PubMed ID: 31196157
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA KB-1980E6.3 promotes breast cancer progression through the PI3K/AKT signalling pathway.
He L; Tang L; Wang R; Liu L; Zhu P; Jiang K; Tu G
Pathol Res Pract; 2022 Jun; 234():153891. PubMed ID: 35461041
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of long non-coding RNA DBH-AS1 inhibits osteosarcoma progression by PI3K-AKT signaling pathways and indicates good prognosis.
Liu ZB; Wang JA; Lv RQ
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1418-1427. PubMed ID: 30840262
[TBL] [Abstract][Full Text] [Related]
18. LINC02381 aggravates breast cancer through the miR-1271-5p/FN1 axis to activate PI3K/AKT pathway.
Huang S; Huang P; Wu H; Wang S; Liu G
Mol Carcinog; 2022 Mar; 61(3):346-358. PubMed ID: 34882856
[TBL] [Abstract][Full Text] [Related]
19. Circular RNA_0000326 promotes bladder cancer progression via microRNA-338-3p/ETS Proto-Oncogene 1/phosphoinositide-3 kinase/Akt pathway.
Chen Y; Wang D; Shu T; Sun K; Zhao J; Wang M; Huang Y; Wang P; Zheng H; Cai Z; Yang Z
Bioengineered; 2021 Dec; 12(2):11410-11422. PubMed ID: 34889689
[TBL] [Abstract][Full Text] [Related]
20. NUF2 promotes tumorigenesis by interacting with HNRNPA2B1 via PI3K/AKT/mTOR pathway in ovarian cancer.
Ren M; Zhao H; Gao Y; Chen Q; Zhao X; Yue W
J Ovarian Res; 2023 Jan; 16(1):17. PubMed ID: 36670423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]